People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GLYSENS Inc | — | Other Health Care | Series B | $20.0M | $443.1M | 2015 |
| RxWare, Inc. | — | Other Health Care | Series A | $10.7M | $20.0M | 2019 |
Adam E. Fine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam E. Fine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam Fine | 1 | 4 |
| David Matias | 1 | 3 |
| Orville G. Kolterman | 1 | 3 |
| Harry Totonis | 1 | 3 |
| Aaron Ganz | 1 | 3 |
| William H Markle | 1 | 2 |
| Gregg Dearhammer | 1 | 2 |
| SAMUEL V. GOEKJIAN | 1 | 1 |
| JOSEPH Y. LUCISANO | 1 | 1 |
| ROBERT L. ENGLER | 1 | 1 |
| KNOX G. BELL | 1 | 1 |
| Raeanna Lewarne | 1 | 1 |
| Shlomi Aflalo | 1 | 1 |
| Farhan Ashraf | 1 | 1 |
| Gregg E. Dearhammer | 1 | 1 |
| Ori E. Karev | 1 | 1 |
| Yishai Knobel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.